ACTA1 Gene Myopathy, scapulohumeroperoneal NGS Genetic Test
Short Name: ACTA1 Myopathy NGS Genetic Test
Also known as: Nemaline myopathy type 3 genetic test, ACTA1-related congenital myopathy NGS test, Scapulohumeroperoneal myopathy gene test
ACTA1 Gene Myopathy, scapulohumeroperoneal NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS) on Blood samples. Results in Reports are generally available in 3 to 4 weeks after the sample reaches the laboratory and the genetic analysis is completed.. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr SULOCHANA HEMCHANDRA HOLLA
Consultant Medical Geneticist · Reg: 8532
Last reviewed: September 7, 2026
Overview
This test is intended to identify clinically significant variants in the ACTA1 gene in individuals with suspected ACTA1-related myopathy. It helps confirm the diagnosis, estimate recurrence risk, enable carrier testing in at-risk family members and guide disease management decisions.
- Test Code
- 4391
- Price
- ₹20,000
- Sample Type
- Blood
- Result Time
- Reports are generally available in 3 to 4 weeks after the sample reaches the laboratory and the genetic analysis is completed.
- Fasting Required
- No
- Method
- Next Generation Sequencing (NGS)
Sample Collection
A genetic counselling session to draw a pedigree chart of family members affected with ACTA1 Gene Myopathy, scapulohumeroperoneal is required before testing. Please carry relevant clinical records and any prior family genetic test reports.
Method: Venipuncture
Laboratory Analysis
A blood sample will be collected from a vein in the arm. The procedure takes about 5 to 10 minutes. Inform the phlebotomist if you have a bleeding disorder or are on blood thinners.
Report Delivery
You can resume normal activities immediately after sample collection. The blood sample will be transported to the laboratory for NGS analysis.
Timeline: Reports are generally available in 3 to 4 weeks after the sample reaches the laboratory and the genetic analysis is completed.
Patient Instructions
About This Test
Who Should Get This Test
This test is intended to identify clinically significant variants in the ACTA1 gene in individuals with suspected ACTA1-related myopathy. It helps confirm the diagnosis, estimate recurrence risk, enable carrier testing in at-risk family members and guide disease management decisions.
How to Prepare
- Confirm the genetic counselling appointment before sample collection
- No fasting is required
- Use the labelled blood collection tube provided by the laboratory
- Complete the informed consent and sample labelling process
Doctor's Notes
Reviewed by Dr SULOCHANA HEMCHANDRA HOLLA — MBBS, MD (Medical Genetics) · Reg. No. 8532
"In suspected neuromuscular disorders, NGS-based genetic testing can support a definitive diagnosis and guide surveillance and family counselling."
Last medically reviewed: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Hemolyzed or clotted blood sample
- Unlabelled or mislabelled sample
- Sample received without signed consent or counselling documentation
- Expired or inappropriate collection tube
Understanding Your Results
Consistent with ACTA1-related myopathy. Clinical correlation and genetic counselling are strongly recommended.
Result type: Pathogenic or likely pathogenic variant detected
Insufficient evidence to classify the variant as disease-causing. Additional family studies or functional analysis may be required.
Result type: Variant of uncertain significance detected
ACTA1-related myopathy is less likely, but not completely excluded. Consider a broader myopathy panel or further clinical evaluation.
Result type: No pathogenic variant detected
If the test result shows a pathogenic variant, or if symptoms persist despite a negative genetic test, consult a neurologist or clinical geneticist for further evaluation and management.
Limitations
- ⚠This test does not rule out all causes of myopathy
- ⚠Absence of a pathogenic variant does not exclude ACTA1 gene-related disease
- ⚠Non-coding or deep intronic variants may not be detected by standard NGS
- ⚠Large structural rearrangements may require additional testing
- ⚠Results should always be interpreted in the context of clinical findings and family history
Risks & Considerations
- ●Minor pain or bruising at the blood collection site
- ●No significant physical risk associated with the blood draw
- ●Potential psychological impact of genetic results, including implications for family members
Interfering Factors
- ●Low DNA concentration or degraded DNA
- ●Incomplete NGS coverage in certain gene regions
- ●Presence of large deletions or duplications not detectable by standard NGS
- ●Prior allogeneic bone marrow transplant affecting blood DNA results
Compare With Similar Tests
| Test | ACTA1 Gene Myopathy, scapulohumeroperoneal NGS Genetic Test | |||
|---|---|---|---|---|
| Comparison | ACTA1 Gene Myopathy, scapulohumeroperoneal NGS Genetic Test |
Frequently Asked Questions
What is ACTA1 gene myopathy?
Why is this NGS genetic test done?
What is the cost of this ACTA1 NGS genetic test?
Is fasting required before the test?
What sample is collected for the test?
How long will the reports take?
Who should consider this genetic test?
Does the test detect all types of ACTA1 mutations?
Where is this test available in India?
Is home sample collection available?
Are there any risks from the test?
Do I need genetic counselling after the result?
Related Tests
Angelman Syndrome Test
₹10,000Duchenne / Becker Muscular Dystrophy (DMD / BMD) Gene Mutation Test
₹14,000Episodic Ataxia Type 1 Hotspot Test
₹11,500Episodic Ataxia Comprehensive Profile Hotspot Test
₹16,000Megalencephalic Leukoencephalopathy with Subcortical Cysts Van Der Knaap and Nalband MLC Gene Hotspot Mutation Test
₹7,500Analyzer 18 SMA 18 Test Panel
₹1,755Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.
